BR112015001843A2 - dispositivo médico, composição de matriz biodegradável e método para tratar um paciente. - Google Patents
dispositivo médico, composição de matriz biodegradável e método para tratar um paciente.Info
- Publication number
- BR112015001843A2 BR112015001843A2 BR112015001843A BR112015001843A BR112015001843A2 BR 112015001843 A2 BR112015001843 A2 BR 112015001843A2 BR 112015001843 A BR112015001843 A BR 112015001843A BR 112015001843 A BR112015001843 A BR 112015001843A BR 112015001843 A2 BR112015001843 A2 BR 112015001843A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- treating
- medical device
- matrix composition
- biodegradable matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261678655P | 2012-08-02 | 2012-08-02 | |
| US61/678,655 | 2012-08-02 | ||
| US201261739792P | 2012-12-20 | 2012-12-20 | |
| US61/739,792 | 2012-12-20 | ||
| US201361778791P | 2013-03-13 | 2013-03-13 | |
| US61/778,791 | 2013-03-13 | ||
| PCT/IL2013/050657 WO2014020610A1 (en) | 2012-08-02 | 2013-08-01 | Compositions and methods for the treatment of bone voids and open fractures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015001843A2 true BR112015001843A2 (pt) | 2017-07-04 |
| BR112015001843B1 BR112015001843B1 (pt) | 2021-05-11 |
Family
ID=50027362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015001843-2A BR112015001843B1 (pt) | 2012-08-02 | 2013-08-01 | composição farmacêutica e uso da mesma |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9173976B2 (pt) |
| EP (1) | EP2879620B1 (pt) |
| JP (1) | JP6182213B2 (pt) |
| KR (1) | KR101883807B1 (pt) |
| CN (1) | CN104519834B (pt) |
| AU (1) | AU2013298102B2 (pt) |
| BR (1) | BR112015001843B1 (pt) |
| CA (1) | CA2880130C (pt) |
| EA (1) | EA027543B1 (pt) |
| ES (1) | ES2802025T3 (pt) |
| HK (1) | HK1204545A1 (pt) |
| IL (1) | IL236823A0 (pt) |
| IN (1) | IN2015DN01553A (pt) |
| MX (1) | MX366048B (pt) |
| NZ (1) | NZ704066A (pt) |
| PH (1) | PH12015500226B1 (pt) |
| SG (1) | SG11201500403RA (pt) |
| WO (1) | WO2014020610A1 (pt) |
| ZA (1) | ZA201500559B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170246112A1 (en) | 2014-10-02 | 2017-08-31 | Polypid Ltd. | Compositions and methods for the treatment and prophylaxis of surgical site infections |
| CA2961998C (en) * | 2014-10-02 | 2022-07-26 | Polypid Ltd. | Methods for the treatment of peri-implantitis |
| US10485902B2 (en) | 2015-08-28 | 2019-11-26 | Thomas Jefferson University | Antibiotic drug release sheath |
| US10029031B2 (en) * | 2015-10-28 | 2018-07-24 | Warsaw Orthopedic, Inc. | Bone void filler having sustained therapeutic agent release |
| FR3064482B1 (fr) * | 2017-04-03 | 2020-11-13 | Horus Pharma | Composition topique de doxycycline |
| WO2020163425A1 (en) * | 2019-02-05 | 2020-08-13 | Flightpath Biosciences, Inc. | Azlocillin and disulfiram-based formulations and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69940735D1 (de) * | 1998-07-17 | 2009-05-28 | Pacira Pharmaceuticals Inc | Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen |
| EP2217260B1 (en) * | 2007-12-04 | 2016-11-09 | Ben-Gurion University Of The Negev Research And Development Authority | Amphiphilic peptide matrices for treatment of osteoporosis |
| PL2299953T3 (pl) * | 2008-07-14 | 2017-10-31 | Polypid Ltd | Kompozycja nośnika leku o przedłużonym uwalnianiu |
| IN2012DN00570A (pt) * | 2009-07-14 | 2015-06-12 | Polypid Ltd |
-
2013
- 2013-08-01 MX MX2015001365A patent/MX366048B/es active IP Right Grant
- 2013-08-01 ES ES13826014T patent/ES2802025T3/es active Active
- 2013-08-01 KR KR1020157005232A patent/KR101883807B1/ko active IP Right Grant
- 2013-08-01 CA CA2880130A patent/CA2880130C/en active Active
- 2013-08-01 BR BR112015001843-2A patent/BR112015001843B1/pt active IP Right Grant
- 2013-08-01 EP EP13826014.6A patent/EP2879620B1/en active Active
- 2013-08-01 US US14/418,138 patent/US9173976B2/en active Active
- 2013-08-01 CN CN201380040312.9A patent/CN104519834B/zh active Active
- 2013-08-01 JP JP2015524903A patent/JP6182213B2/ja active Active
- 2013-08-01 AU AU2013298102A patent/AU2013298102B2/en active Active
- 2013-08-01 EA EA201590049A patent/EA027543B1/ru not_active IP Right Cessation
- 2013-08-01 WO PCT/IL2013/050657 patent/WO2014020610A1/en active Application Filing
- 2013-08-01 NZ NZ704066A patent/NZ704066A/en unknown
- 2013-08-01 SG SG11201500403RA patent/SG11201500403RA/en unknown
-
2015
- 2015-01-20 IL IL236823A patent/IL236823A0/en active IP Right Grant
- 2015-01-26 ZA ZA2015/00559A patent/ZA201500559B/en unknown
- 2015-02-02 PH PH12015500226A patent/PH12015500226B1/en unknown
- 2015-02-25 IN IN1553DEN2015 patent/IN2015DN01553A/en unknown
- 2015-05-29 HK HK15105176.8A patent/HK1204545A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12015500226A1 (en) | 2015-04-06 |
| EA201590049A1 (ru) | 2015-08-31 |
| ES2802025T3 (es) | 2021-01-15 |
| IN2015DN01553A (pt) | 2015-07-03 |
| PH12015500226B1 (en) | 2015-04-06 |
| JP6182213B2 (ja) | 2017-08-16 |
| MX2015001365A (es) | 2015-09-07 |
| EA027543B1 (ru) | 2017-08-31 |
| IL236823A0 (en) | 2015-03-31 |
| KR101883807B1 (ko) | 2018-07-31 |
| WO2014020610A1 (en) | 2014-02-06 |
| NZ704066A (en) | 2017-06-30 |
| US20150202349A1 (en) | 2015-07-23 |
| US9173976B2 (en) | 2015-11-03 |
| JP2015527131A (ja) | 2015-09-17 |
| KR20150038488A (ko) | 2015-04-08 |
| CA2880130A1 (en) | 2014-02-06 |
| BR112015001843B1 (pt) | 2021-05-11 |
| CA2880130C (en) | 2019-09-24 |
| EP2879620A1 (en) | 2015-06-10 |
| EP2879620A4 (en) | 2016-04-13 |
| SG11201500403RA (en) | 2015-02-27 |
| EP2879620B1 (en) | 2020-04-22 |
| CN104519834B (zh) | 2016-10-12 |
| AU2013298102A1 (en) | 2015-02-12 |
| MX366048B (es) | 2019-06-26 |
| CN104519834A (zh) | 2015-04-15 |
| HK1204545A1 (en) | 2015-11-27 |
| AU2013298102B2 (en) | 2017-09-07 |
| ZA201500559B (en) | 2016-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014025726A2 (pt) | mecanismo, sistema e método para tratamento endodôntico | |
| BR112015001098A2 (pt) | composto, composição farmacêutica e método para o tratamento de uma condição de doença. | |
| BR112014023937A2 (pt) | composição farmacêutica, agente farmacêutico de combinação e método de tratamento | |
| BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
| BR112015003847A2 (pt) | dispositivo flexível, e método para operar um dispositivo flexível | |
| BR112015011271A2 (pt) | cortina medicinal, sistema para o tratamento de um tecido local com a pressão reduzida, método para fabricar uma cortina medicinal, e método para o tratamento de um tecido local com a pressão reduzida | |
| BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
| BRPI1012642A2 (pt) | formulação de insulina e método para o tratamento de um indivíduo diabético. | |
| BR112013019637A2 (pt) | sistemas, aparelho e métodos para implantação de implantes | |
| BR112015002868A2 (pt) | dispositivos, sistemas e métodos para se engajar tecido | |
| EP2810598A4 (en) | SURGICAL SUPPORT DEVICE, SURGICAL SUPPORT METHOD, AND SURGICAL SUPPORT PROGRAM | |
| BRPI0910969A2 (pt) | dispositivo, método para preparar em dispositivo, e, método para tratar um paciente | |
| BR112014031522A2 (pt) | métodos para inibir a ativação de complemento dependente de masp-3, para inibir a ativação de complemento dependente de masp-2 e para fabricar um medicamento | |
| BR112013011968A2 (pt) | composição farmacêutica, métodos de tratamento e usos da mesma | |
| BR112015003845A2 (pt) | aparelho flexível, e método para controlar um aparelho flexível | |
| BR112014026570A2 (pt) | microagulha, arranjo e dispositivo de microagulha, e, método para administração de uma droga | |
| BR112015007061A2 (pt) | composto, composição farmacêutica e método para tratar uma condição ou distúrbio dependente de apkc em um paciente | |
| BR112014001962A2 (pt) | dispositivo, sistema e método para restauração prostodôntica | |
| BR112013004456A2 (pt) | composição para tratamento de planta, e, método para o tratamento de plantas | |
| EP3068442A4 (en) | Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent | |
| BR112014004192A2 (pt) | composição de tratamento de sementes, e, método de tratamento de sementes | |
| BR112014031896A2 (pt) | composto, composição farmacêutica, e, método para o tratamento de um distúrbio | |
| BR112013010102A2 (pt) | microagulha, arranjo de microagulhas, dispositivo de microagulhas, e, método para administrar um agente medicinal | |
| BR112013016491A2 (pt) | método para tratamento de têxtil | |
| BR112015001843A2 (pt) | dispositivo médico, composição de matriz biodegradável e método para tratar um paciente. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61F 2/28 (2006.01), A61K 47/00 (2006.01), A61K 33 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2013, OBSERVADAS AS CONDICOES LEGAIS. |